Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.

The preference of the apolipoprotein (apo) B/apoA-I ratio over the total cholesterol/HDL cholesterol (TC/HDL-C) ratio in cardiovascular risk prediction is disputed. Cholesteryl ester transfer protein (CETP) is instrumental in lipoprotein remodelling and affects the cholesterol content in pro- and antiatherogenic lipoproteins relative to their major apolipoproteins. We tested the influence of common CETP variations on the strength of associations of a first major adverse cardiovascular event (MACE) with the apoB/apoA-I ratio compared with the TC/HDL-C ratio. A prospective case-cohort study was performed (PREVEND cohort; no previous cardiovascular disease and no use of lipid-lowering drugs initially). Fasting serum TC/HDL-C, apoB/apoA-I, triglycerides, and common CETP variations (TaqIB [rs708272] and -629C>A [rs1800775] polymorphisms) were measured at baseline. The composite end point was incident MACE. A total of 532 of 6780 subjects experienced a first MACE during 10.8 years follow-up. The age- and sex-adjusted hazard ratio was 1.31 (95 % confidence interval 1.23-1.41) for the apoB/apoA-I ratio and 1.22 (95% confidence interval 1.26-1.39) for the TC/HDL-C ratio (both P < .001). These relationships were essentially similar within each TaqIB and -629C>A CETP genotype group. No interactions of the apoB/apoA-I ratio and the TC/HDL-C ratio with the TaqIB and the -629C>A CETP variations on incident MACE were observed (P > .20 for all). The relationship of first MACE with the TC/HDL-C and the apoB/apoA-I ratio is not to an important extent dependent on common CETP variations. CETP variations are unlikely to affect the strength of the relationship of first MACE with the apoB/apoA-I ratio compared with the TC/HDL-C ratio.

Kappelle PJ ，Gansevoort RT ，Hillege HJ ，Wolffenbuttel BH ，Dullaart RP ，PREVEND Study Group ... -  《-》

An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.

Borggreve SE ，Hillege HL ，Wolffenbuttel BH ，de Jong PE ，Zuurman MW ，van der Steege G ，van Tol A ，Dullaart RP ，PREVEND Study Group ... -  《JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM》

Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.

Oksala N ，Seppälä I ，Hernesniemi J ，Lyytikäinen LP ，Kähönen M ，Mäkelä KM ，Reunanen A ，Jula A ，Ala-Korpela M ，Lehtimäki T ... -  《-》

The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.

Borggreve SE ，Hillege HL ，Wolffenbuttel BH ，de Jong PE ，Bakker SJ ，van der Steege G ，van Tol A ，Dullaart RP ，PREVEND Study Group ... -  《JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM》

Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.

Sniderman AD ，Jungner I ，Holme I ，Aastveit A ，Walldius G ... -  《JOURNAL OF INTERNAL MEDICINE》